Clearside Biomedical, Inc.
Case Number:
1:25-bk-12109
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
February 23, 2026
Saks' $5B DIP Gets Final OK, Biotech Co. Wants Credit Bid Bar
Luxury retailer Saks can access the final portion of a more than $5 billion Chapter 11 loan, the Roman Catholic Diocese of Oakland and its creditors' committee will submit competing Chapter 11 plans, and a biotech firm says a last-minute bid change has stifled bankruptcy auction competition.
-
February 20, 2026
Clearside Bio Wants Block On $100M Bid That 'Froze' Auction
Clearside Biomedical has urged a Delaware bankruptcy judge to block a KKR & Co.-owned firm from credit bidding some $100 million in allegedly secured debt in its Chapter 11 auction, saying the last-minute offer amounted to an "ambush" that "froze" competition.
-
December 19, 2025
Biomedical Co. Gets Approval For Ch. 11 Auction In January
Eye disease treatment developer Clearside Biomedical on Friday got permission from a Delaware bankruptcy judge for a January auction of its assets after saying it had resolved objections from shareholders and the U.S. Trustee's Office.
-
December 02, 2025
Catching Up With New Bankruptcy Case Action
A solar energy business sought bankruptcy protection in Texas. The foreign representative of a consultancy founder's bankruptcy estate sought recognition of his Canadian insolvency proceedings. And a landlord in the Bronx entered Chapter 11.
-
December 01, 2025
Meet The Attorneys Leading Clearside Biomedical's Ch. 11
A team of lawyers from Richards Layton & Finger PA and Cooley LLP is representing Clearside Biomedical, a company developing treatments for eye diseases, in a recently filed Chapter 11 case as it looks to sell its business.
-
November 25, 2025
Catching Up With New Bankruptcy Case Action
National home goods retailer American Signature Furniture filed for Chapter 11 after seeing a slump in sales compounded by macroeconomic conditions. A Canadian oil and natural gas driller asked for Chapter 15 recognition of its restructuring efforts. And two pharmaceutical developers filed for bankruptcy, with one looking to hold a Chapter 11 sale of its assets and the other eyeing a Chapter 7 liquidation.
-
November 25, 2025
Biomedical Co. Gets First-Day Ch. 11 Relief Amid Sale Push
Clearside Biomedical Inc., a company that develops treatments for serious eye diseases, received a Delaware bankruptcy judge's permission Tuesday to pay contractors' wages and prepetition taxes as the company kicks off a Chapter 11 case designed to help find a buyer for its assets.
-
November 24, 2025
Ophthalmic Co. Hits Ch. 11 With $64M Debt, Eyeing Sale
Clearside Biomedical, a company developing treatments for eye diseases, has filed for Chapter 11 protection in Delaware bankruptcy court with $64 million in debt, saying it will attempt to sell its business during the case.